BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 3164706)

  • 1. Role of pressor prostanoids in rats with angiotensin II-salt-induced hypertension.
    Mistry M; Nasjletti A
    Hypertension; 1988 Jun; 11(6 Pt 2):758-62. PubMed ID: 3164706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal function in rats with angiotensin II-salt-induced hypertension: effect of thromboxane synthesis inhibition and receptor blockade.
    Mistry M; Muirhead EE; Yamaguchi Y; Nasjletti A
    J Hypertens; 1990 Jan; 8(1):75-83. PubMed ID: 2157760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting effect of thromboxane synthase inhibitors and a thromboxane receptor antagonist on the development of angiotensin II-salt-induced hypertension in rats.
    Mistry M; Nasjletti A
    J Pharmacol Exp Ther; 1990 Apr; 253(1):90-4. PubMed ID: 2139470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TXA2 in the pathogenesis of severe angiotensin II-salt hypertension.
    Mistry M; Nasjletti A
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():207-10. PubMed ID: 2526469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction.
    Lin L; Nasjletti A
    Hypertension; 1991 Aug; 18(2):158-64. PubMed ID: 1885223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboxane mediates renal hemodynamic response to infused angiotensin II.
    Wilcox CS; Welch WJ; Snellen H
    Kidney Int; 1991 Dec; 40(6):1090-7. PubMed ID: 1837063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous prostaglandin endoperoxides may alter infarct size in the presence of thromboxane synthase inhibition: studies in a rabbit model of coronary artery occlusion-reperfusion.
    Golino P; Ambrosio G; Villari B; Ragni M; Focaccio A; Pace L; de Clerk F; Condorelli M; Chiariello M
    J Am Coll Cardiol; 1993 Feb; 21(2):493-501. PubMed ID: 8426016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction augments myogenic arteriolar constriction in hypertension.
    Huang A; Sun D; Koller A
    Hypertension; 1993 Dec; 22(6):913-21. PubMed ID: 8244524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of prostanoids in renin-dependent and renin-independent hypertension.
    Lin L; Mistry M; Stier CT; Nasjletti A
    Hypertension; 1991 Apr; 17(4):517-25. PubMed ID: 2013478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J; McGiff JC; Nasjletti A
    Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contractile effect of endothelin in human placental veins: role of endothelium prostaglandins and thromboxane.
    Le SQ; Wasserstrum N; Mombouli JV; Vanhoutte PM
    Am J Obstet Gynecol; 1993 Oct; 169(4):919-24. PubMed ID: 8238149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of renin by thromboxane: studies with thromboxane synthase inhibitor, receptor antagonists, and mimetic.
    Welch WJ; Wilcox CS; Dunbar KR
    Am J Physiol; 1989 Oct; 257(4 Pt 2):F554-60. PubMed ID: 2508488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal vascular interaction of angiotensin II and prostaglandins in renovascular hypertension.
    Cruz BV; Escalante B
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):21-7. PubMed ID: 10413062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thromboxane mediation of the pressor response to infused angiotensin II.
    Wilcox CS; Welch WJ
    Am J Hypertens; 1990 Mar; 3(3):242-9. PubMed ID: 2322437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of eicosanoids on renal function of DOCA-salt hypertensive rats.
    Roman RJ; Kaldunski ML; Mattson DL; Mistry M; Nasjletti A
    Hypertension; 1988 Sep; 12(3):287-94. PubMed ID: 3169943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
    Valentin JP; Bessac AM; Maffre M; John GW
    Eur J Pharmacol; 1996 Dec; 317(2-3):335-42. PubMed ID: 8997619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of thromboxane actions in the isolated perfused rat heart.
    Stahl GL; Darius H; Lefer AM
    Life Sci; 1986 Jun; 38(22):2037-41. PubMed ID: 2940431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the thromboxane receptor antagonist SQ 29,548 on myocardial infarct size in dogs.
    Grover GJ; Schumacher WA
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):29-35. PubMed ID: 2450253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of thromboxane and the prevention of eicosanoid-induced sudden death in mice.
    Darius H; Lefer AM
    Proc Soc Exp Biol Med; 1985 Nov; 180(2):364-8. PubMed ID: 2996012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane A2 receptor mediation of calcium and calcium transients in rat cardiomyocytes.
    Dogan S; Turnbaugh D; Zhang M; Cofie DQ; Fugate RD; Kem DC
    Life Sci; 1997; 60(12):943-52. PubMed ID: 9061051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.